«
»

Mesothelioma Patient

mesothelioma patient
CytRx’ bafetinib receives EMEA COMP positive opinion for treatment of CML
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that bafetinib (formerly known as INNO-406) has received official notification from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMEA) that a positive opinion was made regarding the application for orphan medicinal product for the treatment of chronic myeloid leukemia …
Mesothelioma Patient Legal Help and Support


Related Sites

    Tags: , , , , , , , , ,

    This entry was posted on Thursday, March 27th, 2008 at 4:15 pm and is filed under Lawyer Mesothelioma Settlement. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

    2 Responses to “Mesothelioma Patient”

    1. Bethanie Packham Says:
      May 9th, 2010 at 12:39 am

      M4L – : Texas Mesothelioma Lawyers http://mesothelioma-life-expectancy.info/texas-mesothelioma-lawyers/

    2. Savanna Why Says:
      May 11th, 2010 at 9:59 am

      Renovations of former Air Force station lead to asbestos charges for two men http://bit.ly/9czAzZ

    Leave a Reply